Exogene

Exogene Raises $2 million for its AI platform to Discover Cell Therapies for Cancer

Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.
Oxford BioEscalator, Innovation Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ